Molecular Transfer Inc. Acquires GlobalStem - Expands into Stem Cell and Neuroscience Research Markets
News Apr 21, 2010
Molecular Transfer Inc. (MTI) is expanding into stem cell and neuroscience research markets through the acquisition of GlobalStem. The all-cash acquisition will allow MTI to strategically bring together both companies’ technologies and expertise to expand into these rapidly growing research areas.
GlobalStem, Inc. is known for high-quality standardized tools and reagents used in stem cell research and for its contract services to ensure the identity, stability and integrity of stem cell lines. The company’s sales are growing in excess of 50% annually. MTI has retained all of GlobalStem’s employees and their lab facilities and plans to expand the group to meet the strong projected growth and to provide support for their substantial customer base. Dr. Jonathan Auerbach, CEO of GlobalStem, will become President and CSO of MTI’s new GlobalStem division.
"Merging the two companies brings together proven experts in transfection, neurobiology and stem cell biology. This scientific expertise combined with MTI’s product development experience will allow MTI to provide novel solutions to the stem cell and neurobiology markets,” said Joel Jessee, CEO at MTI. “Our initial focus will be to leverage our proprietary transfection technology with stem cells, including reprogrammed stem cells, and introduce novel products, directly and through OEM relationships”.
Jonathan Auerbach added, “All of us at GlobalStem are excited about the opportunity to join MTI and grow our core business. The combined company’s ability to transfect various molecules into stem cells, primary cells and neuronal cells will be a valuable combination for our customers.”
New Blood and Urine Tests Indicate Autism in ChildrenNews
New tests, developed by researchers at the University of Warwick, could lead to earlier diagnosis of the condition.READ MORE
Stem-Cell Exosome Treatment Repairs Brain Damage Following StrokeNews
A team of researchers have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018